Top segments and regional performance

Last year, the company generated ‪6.07 B‬ USD, the most of which — ‪4.49 B‬ USD — came from its top-performing segment, Transcatheter Aortic Valve Replacement, compared to ‪4.11 B‬ USD the previous year. The greatest contribution came from United States, which accounted for ‪3.54 B‬ USD last year, with ‪3.21 B‬ USD the year before.